DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates

DarioHealth, which belongs to the Zacks Medical - Instruments industry, posted revenues of $5.76 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 3.23%. This compares to year-ago revenues of $7.07 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the ...